Bath & Body Works (NYSE:BBWI) Issues FY 2026 Earnings Guidance

Posted by George Bondi on Aug 26th, 2026

Bath & Body Works (NYSE:BBWI – Get Free Report) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.600-2.800 for the period, compared to the consensus estimate of 2.560. The company issued revenue guidance of $7.5 billion-$7.6 billion, compared to the consensus revenue estimate of $7.0 billion. Bath & Body Works also updated its Q3 2026 guidance to 0.070-0.120 EPS.

Analysts Set New Price Targets

BBWI has been the subject of a number of recent analyst reports. Piper Sandler began coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. UBS Group restated a “neutral” rating on shares of Bath & Body Works in a research note on Wednesday, August 19th. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. JPMorgan Chase & Co. raised their target price on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research note on Tuesday, August 18th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $22.00 price target on shares of Bath & Body Works in a report on Monday, July 6th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Hold” and an average price target of $22.57.

Check Out Our Latest Report on BBWI

Bath & Body Works Price Performance

NYSE:BBWI opened at $17.58 on Wednesday. Bath & Body Works has a one year low of $14.27 and a one year high of $32.32. The company has a market cap of $3.54 billion, a P/E ratio of 4.94, a P/E/G ratio of 1.89 and a beta of 1.38. The firm’s fifty day moving average price is $20.39 and its two-hundred day moving average price is $20.03.

Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company’s revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 earnings per share. As a group, equities research analysts expect that Bath & Body Works will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be paid a $0.20 dividend. The ex-dividend date is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 4.6%. Bath & Body Works’s dividend payout ratio is 22.47%.

Institutional Investors Weigh In On Bath & Body Works

Several hedge funds have recently bought and sold shares of the stock. AQR Capital Management LLC grew its position in shares of Bath & Body Works by 132.5% in the fourth quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after purchasing an additional 6,523,960 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock worth $171,904,000 after purchasing an additional 315,738 shares during the last quarter. Bank of America Corp DE lifted its holdings in Bath & Body Works by 86.9% during the 3rd quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock worth $87,568,000 after purchasing an additional 1,580,176 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in Bath & Body Works in the 4th quarter valued at $54,785,000. Finally, Dimensional Fund Advisors LP boosted its stake in Bath & Body Works by 2.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,636,642 shares of the company’s stock valued at $52,945,000 after purchasing an additional 62,560 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.